QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BBOT

QT59BridgeBio Oncology Therapeutics Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
7.56
-0.12-1.56%
OverviewShort InterestFilings
BBOTQT59BridgeBio Oncology Therapeutics Inc.·NASDAQ
OverviewShort InterestFilings
7.56-1.56%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
May 13, 2026May 13, 2026424B3424B3
May 12, 2026May 12, 20268-KCurrent report
May 12, 2026May 12, 202610-QQuarterly report
May 12, 2026May 12, 20264Statement of changes in beneficial ownership
May 12, 2026May 12, 20264Statement of changes in beneficial ownership
May 06, 2026May 06, 2026424B3424B3
May 05, 2026May 05, 20264Statement of changes in beneficial ownership
May 05, 2026May 05, 20264Statement of changes in beneficial ownership
May 05, 2026May 05, 20264Statement of changes in beneficial ownership
May 04, 2026May 04, 2026EFFECTEFFECT
Apr 30, 2026Apr 30, 2026POS AMPost-effective amendment
Apr 30, 2026Apr 30, 20263Initial statement of beneficial ownership
Apr 30, 2026Apr 30, 20263Initial statement of beneficial ownership
Apr 29, 2026Apr 29, 20268-KCurrent report
Apr 29, 2026Apr 29, 2026424B3424B3
Apr 28, 2026Apr 28, 2026ARSARS
Apr 28, 2026Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026Apr 23, 2026424B3424B3
Apr 23, 2026Apr 23, 20268-KCurrent report
Mar 26, 2026Mar 26, 20264Statement of changes in beneficial ownership
Mar 26, 2026Mar 26, 20268-KCurrent report
Mar 26, 2026Mar 26, 20263Initial statement of beneficial ownership
Mar 26, 2026Mar 26, 2026424B3424B3
Mar 12, 2026Mar 12, 20264Statement of changes in beneficial ownership
#1 / 25 of 143
Page
▼
/ 6